284 related articles for article (PubMed ID: 17654681)
1. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique.
Konen E; Ghoti H; Goitein O; Winder A; Kushnir T; Eshet Y; Rachmilewitz E
Am J Hematol; 2007 Nov; 82(11):1013-6. PubMed ID: 17654681
[TBL] [Abstract][Full Text] [Related]
2. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
[TBL] [Abstract][Full Text] [Related]
3. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.
Di Tucci AA; Matta G; Deplano S; Gabbas A; Depau C; Derudas D; Caocci G; Agus A; Angelucci E
Haematologica; 2008 Sep; 93(9):1385-8. PubMed ID: 18603557
[TBL] [Abstract][Full Text] [Related]
4. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
5. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
Fragasso A; Ciancio A; Mannarella C; Gaudiano C; Scarciolla O; Ottonello C; Francone M; Nardella M; Peluso A; Melpignano A; Veglio MR; Quarta G; Turchetti C
Eur J Intern Med; 2011 Feb; 22(1):62-5. PubMed ID: 21238896
[TBL] [Abstract][Full Text] [Related]
6. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
Rose C; Vandevenne P; Bourgeois E; Cambier N; Ernst O
Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
8. The deleterious effects of iron overload in patients with myelodysplastic syndromes.
Dreyfus F
Blood Rev; 2008 Dec; 22 Suppl 2():S29-34. PubMed ID: 19059054
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cardiac iron overload in transfusion-dependent adult marrow failure patients by magnetic resonance imaging.
Park J; Ohyashiki K; Akata S; Takara K; Uno R; Kakizaki D; Miyazawa K; Kimura Y; Tokuuye K
Leuk Res; 2009 Jun; 33(6):756-8. PubMed ID: 19038447
[TBL] [Abstract][Full Text] [Related]
10. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
Delforge M; Selleslag D; Triffet A; Mineur P; Bries G; Graux C; Trullemans F; MacDonald K; Abraham I; Pluymers W; Ravoet C
Ann Hematol; 2011 Jun; 90(6):655-66. PubMed ID: 21318574
[TBL] [Abstract][Full Text] [Related]
11. Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.
Pascal L; Beyne-Rauzy O; Brechignac S; Marechaux S; Vassilieff D; Ernst O; Berthon C; Gyan E; Gourin MP; Dreyfus F; Fenaux P; Rose C
Br J Haematol; 2013 Aug; 162(3):413-5. PubMed ID: 23656172
[No Abstract] [Full Text] [Related]
12. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
[TBL] [Abstract][Full Text] [Related]
13. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
[TBL] [Abstract][Full Text] [Related]
14. Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload.
Du Y; Long Z; Chen M; Han B; Hou B; Feng F
Acta Haematol; 2017; 138(2):119-128. PubMed ID: 28866669
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients.
Taher AT; Musallam KM; Wood JC; Cappellini MD
Am J Hematol; 2010 Apr; 85(4):288-90. PubMed ID: 20143405
[No Abstract] [Full Text] [Related]
16. No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia.
Origa R; Barella S; Argiolas GM; Bina P; Agus A; Galanello R
Haematologica; 2008 Jul; 93(7):1095-6. PubMed ID: 18508795
[No Abstract] [Full Text] [Related]
17. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
Jabbour E; Kantarjian HM; Koller C; Taher A
Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
[TBL] [Abstract][Full Text] [Related]
19. Iron overload in MDS-pathophysiology, diagnosis, and complications.
Gattermann N; Rachmilewitz EA
Ann Hematol; 2011 Jan; 90(1):1-10. PubMed ID: 20938663
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients.
Leung AW; Chu WC; Lam WW; Lee V; Li CK
Pediatr Blood Cancer; 2009 Dec; 53(6):1054-9. PubMed ID: 19618454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
